These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 21964529)

  • 41. Tumor invasion of extralobar soft tissue beyond the hilar region does not affect the prognosis of surgically resected lung cancer patients.
    Otsuka H; Ishii G; Yoshida J; Yamaguchi Y; Hishida T; Nishimura M; Nagai K; Ochiai A
    J Thorac Oncol; 2010 Oct; 5(10):1571-5. PubMed ID: 20802347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer.
    Lee YC; Wu CT; Kuo SW; Tseng YT; Chang YL
    Chest; 2007 Apr; 131(4):993-9. PubMed ID: 17426201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution.
    Ditto A; Martinelli F; Lo Vullo S; Reato C; Solima E; Carcangiu M; Haeusler E; Mariani L; Lorusso D; Raspagliesi F
    Ann Surg Oncol; 2013 Nov; 20(12):3948-54. PubMed ID: 23812772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
    Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer.
    Dhillon T; Mauri FA; Bellezza G; Cagini L; Barbareschi M; North BV; Seckl MJ
    J Thorac Oncol; 2010 Mar; 5(3):314-9. PubMed ID: 20093977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers.
    Tanvetyanon T; Robinson L; Sommers KE; Haura E; Kim J; Altiok S; Bepler G
    J Thorac Oncol; 2010 Jul; 5(7):1018-24. PubMed ID: 20453687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
    J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients.
    Nakao M; Yoshida J; Ishii G; Kawase A; Maeda R; Aokage K; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Oct; 5(10):1576-82. PubMed ID: 20802346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.
    Katsumata S; Aokage K; Ishii G; Nakasone S; Sakai T; Okada S; Miyoshi T; Tane K; Tsuboi M
    J Thorac Oncol; 2019 Aug; 14(8):1408-1418. PubMed ID: 31055075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy.
    Zhou H; Tapias LF; Gaissert HA; Muniappan A; Wright CD; Wain JC; Donahue DM; Morse CR; Mathisen DJ; Lanuti M
    Ann Thorac Surg; 2015 Sep; 100(3):910-6. PubMed ID: 26165483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
    Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
    Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.